North America Cold Sore Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 446.54 Billion |
 Market Size (Forecast Year) |
USD 690.51 Billion |
 CAGR |
% |
| Major Markets Players |
北美唇疱疹治疗（针对 HSV 1 病毒）市场，按产品类型（药物、软膏、乳霜、药用润唇膏、唇疱疹贴和非药用产品）、给药途径（口服、外用和其他）、类型（处方药和非处方 (OTC) 药）、性别（男性和女性）、药物类型（品牌药和仿制药）、最终用户（医院、专科诊所、家庭护理环境和其他）、分销渠道（医院药房、网上药房、零售药房和其他）划分 - 行业趋势和预测到 2030 年。
北美唇疱疹治疗（针对 HSV 1 病毒）市场分析与洞察
唇疱疹感染的患病率和发病率不断上升，增加了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场增长。在这一关键时期，主要市场参与者专注于各种服务的推出和批准。此外，对药品研发和生命科学研究的投资增加也促进了对唇疱疹治疗的需求不断增长。
由于市场参与者的增加和先进服务的可用性，北美唇疱疹治疗（针对 HSV 1 病毒）市场预计将在预测年内增长。与此同时，制造商正在从事研发活动，以向市场推出新产品。HSV 传播方式的激增进一步推动了市场增长。然而，对唇疱疹的发病和症状及其治疗缺乏认识可能会阻碍预测期内的市场增长。
北美唇疱疹治疗（针对 HSV 1 病毒）市场预计将在 2023 年至 2030 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场以 5.6% 的复合年增长率增长，预计到 2030 年将从 2022 年的 4.4654 亿美元达到 6.9051 亿美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按产品类型（药物、软膏、乳霜、药用润唇膏、唇疱疹贴和非药用产品）、给药途径（口服、外用和其他）、类型（处方药和非处方 (OTC) 药）、性别（男性和女性）、药品类型（品牌药和仿制药）、最终用户（医院、专科诊所、家庭护理环境和其他）、分销渠道（医院药房、网上药房、零售药房和其他） |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
在市场上交易的主要公司包括葛兰素史克公司 (GSK plc)、诺华公司 (Novartis AG)、Viatris Inc.、Hikma Pharmaceuticals PLC、HRA Pharma、Quantum Health、URGO、Apotex Inc.、Church & Dwight Co., Inc.、Bausch Health Companies Inc.、Zydus Pharmaceuticals Inc.、Haleon Group of Companies、Amparo medical Technologies、Teva Pharmaceuticals USA Inc.、Carma Labs Inc. 和 Blistex Inc. 等 |
市场定义
唇疱疹或口腔疱疹是由于单纯疱疹病毒 (HSV) 感染而出现的小水泡状擦伤。唇疱疹通常发生在面部、嘴唇周围、下巴、脸颊和鼻孔。它们通常会在破裂前引起疼痛和瘙痒。HSV 是影响全球人口的最常见病毒之一，在世界各地流行。全世界多达 90% 的人至少患有一种形式的 HSV。它通常会感染全世界的儿童人群，但根据世界卫生组织的数据，30-49 岁的人现在感染病毒的风险更高，而且 HSV 的患病率会随着年龄的增长而增加。
北美唇疱疹治疗（针对 HSV 1 病毒）市场动态
司机
-
唇疱疹感染患病率不断上升
由单纯疱疹病毒 (HSV) 引起的一组小而疼痛的水疱被称为唇疱疹。它们也被称为发热性疱疹或口腔疱疹。HSV 是影响全球人口的最常见病毒之一，在世界各地流行。
例如，
-
据世界卫生组织估计，全球 50 岁以下感染 HSV-1 的人估计超过 37 亿（67%）
-
根据美国疾病控制与预防中心 (CDC) 的数据，国家健康和营养检查调查的数据显示，全球范围内，女性 HSV-1 的患病率高于男性。HSV 的患病率也随着年龄的增长而增加。
-
根据美国疾病控制与预防中心的数据，2012 年美国 0-49 岁人群中 HSV-1 感染者包括 1.78 亿女性，占女性人口的 49%
通过这些实例，我们可以得出结论，唇疱疹感染的日益流行正在推动市场的增长。
-
单纯疱疹病毒传播方式的扩散
传染性病毒可以通过不同的方式传播，从其自然宿主传播到易感宿主。HSV 感染的传播依赖于易感人群与排泄 HSV 病毒的人之间的亲密个人互动。传播方式有不同的分类，包括直接传播和间接传播。
HSV 通常通过直接传播，包括直接接触或飞沫传播。HSV-1 传播的主要方式是通过口对口接触诱发口腔疱疹感染，通过接触唾液、溃疡和口腔内或周围表面中的 HSV。此外，不卫生的做法、无保护的性交和口交是增加人与人之间 HSV 传播的主要方式。此外，HSV 可以通过接触传播，例如接吻、用同一个餐具进食、共用杯子、毛巾或马桶座圈以及共用润唇膏。因此，传染病传播方式的增加预计将推动市场增长。
机会
-
增加唇疱疹贴的使用
唇疱疹病例的增加为市场参与者创造了大量机会，并可能激增对治疗 HSV-1 感染或相关疾病所需治疗方案的需求。出于这个原因，各主要市场参与者正在加大对 HSV 研究的投资，以提出新的治疗方案。
治疗唇疱疹的技术取得了多项进步，包括所有旨在引入新技术（疫苗、疗法、药物和贴剂）治疗唇疱疹的医学研究。贴剂因其对治疗唇疱疹的有效性而一直受到追捧。
此外，主要市场参与者采取的战略举措将为 2023-2030 年预测期内的市场增长提供结构完整性和未来机会。
克制/挑战
- 对唇疱疹的发生和症状以及治疗缺乏认识
人们对唇疱疹的发病和症状缺乏认识，以及部分上市药物的专利终止，将阻碍市场的增长速度。此外，治疗唇疱疹的药物的副作用也将进一步阻碍市场的增长。
最新动态
- 2022 年 10 月，葛兰素史克公司与美国精准医疗公司 Tempus 签署了一项为期三年的合作协议，该协议允许葛兰素史克使用 Tempus 的人工智能平台，包括其去识别患者数据库。通过其领先的人工智能和机器学习 (AI/ML) 能力，葛兰素史克将与 Tempus 合作改进临床试验设计、加快入组速度并确定药物靶点。这将有助于提高葛兰素史克的研发成功率，并更快地为患者提供更个性化的治疗。
- 2022 年 7 月，Haleon 集团宣布完成将医疗保健业务从葛兰素史克集团分拆至 Haleon 集团。Haleon 是全球领先的消费者健康公司，其品牌受到全球数百万消费者的信赖。其产品范围包括五大类别——口腔健康、止痛、呼吸健康、消化健康等，以及维生素、矿物质和膳食补充剂 (VMS)。其长期品牌如 Advil、Sensodyne、Panadol、Voltaren、Theraflu、Otrivin、Polident、Parodontax 和 Centrum 均以可靠的科学、创新和对人的深刻理解为基础。
北美唇疱疹治疗（针对 HSV 1 病毒）市场范围
北美唇疱疹治疗（针对 HSV 1 病毒）市场细分为产品类型、给药途径、类型、性别、药物类型、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
产品类型
- 药物
- 软膏
- 面霜
- 药用润唇膏
- 唇疱疹贴
- 非药用产品
根据产品类型，市场分为药物、药膏、面霜、药用润唇膏、唇疱疹贴和非药用产品。
给药途径
- 口服
- 主题
- 其他的
根据给药途径，市场分为口服、外用和其他。
类型
- 处方药
- 非处方药
根据类型，市场分为处方药和非处方药（OTC）。
性别
- 男性
- 女性
根据性别，市场分为男性和女性。
药物类型
- 品牌
- 泛型
根据药品类型，市场分为品牌药和仿制药。
最终用户
- 医院
- 专科诊所
- 家庭护理环境
- 其他的
根据最终用户，市场分为医院、专科诊所、家庭护理环境和其他。
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
根据分销渠道，市场分为医院药房、网上药房、零售药房和其他。
北美唇疱疹治疗（针对 HSV 1 病毒）市场区域分析/见解
对北美唇疱疹治疗（针对 HSV 1 病毒）市场进行了分析，并按国家、产品类型、给药途径、类型、性别、药物类型、最终用户和分销渠道提供了市场规模洞察和趋势。
在市场份额和市场收入方面，美国在北美市场占据主导地位，并将在预测期内继续保持主导地位。这是由于该地区唇疱疹感染患病率高，研发速度快，从而推动了市场增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新车和替代车销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性、当地和国内品牌激烈竞争所带来的挑战以及销售渠道的影响。
竞争格局和北美唇疱疹治疗（针对 HSV 1 病毒）市场份额分析
北美唇疱疹治疗（针对 HSV 1 病毒）市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
北美唇疱疹治疗（针对 HSV 1 病毒）市场的一些主要参与者包括葛兰素史克公司 (GSK plc.)、诺华公司 (Novartis AG)、Viatris 公司、Hikma Pharmaceuticals PLC、HRA Pharma、Quantum Health、URGO、Apotex 公司、Church & Dwight Co., Inc.、Bausch Health Companies Inc.、Zydus Pharmaceuticals Inc.、Haleon Group of Companies、Amparo medical Technologies、Teva Pharmaceuticals USA, Inc.、Carma Labs 公司和 Blistex 公司等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of NORTH AMERICA Cold Sore Treatment MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- THERAPEUTICS LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET drug type COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Pipeline analysis
- Epidemiology
- market overview
- drivers
- Growing prevalence of cold sore infection
- Proliferation in modes of transmission of herpes simplex virus
- Increasing awareness about sexually transmitted diseases
- Availability of generic drugs
- Rising rate of HSV infection among women
- RESTRAINTS
- Patent termination of marketed drugs
- Risks of other diseases associated with cold sore
- Dearth of awareness about the onset and symptoms of cold sore treatment
- OPPORTUNITIES
- Increasing disposable income
- Strategic Initiatives by market players
- Increasing research and Development
- Increasing use of cold sore patches
- CHALLENGES
- Rise in alternative treatments
- Emergence of drugs resistant to acyclovir
- Side effects Associated with medications used for treating cold sore
- COVID-19 IMPACT ON COLD SORE TREATMENT MARKET
- impact on price
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- strategic decisions for manufacturers
- CONCLUSION
- north america COLD SORE TREATMENT MARKET, BY strain TYPE
- overview
- HERPES SIMPLEX TYPE 1 VIRUS
- HERPES SIMPLEX TYPE 2 VIRUS
- north america COLD SORE TREATMENT MARKET, BY therapeutics
- overview
- ANTIVIRAL AGENTS
- Acyclovir
- Famciclovir
- Penciclovir
- Valacyclovir
- Docosanol
- ANALGESIC AGENTS
- Carmex
- Herpecin
- others
- others
- north america COLD SORE TREATMENT MARKET, BY drug type
- overview
- generics
- otc
- prescription
- branded
- prescription
- otc
- north america COLD SORE TREATMENT MARKET, BY dosage type
- overview
- Oral
- Tablets
- Pills
- TOPICAL
- cream
- Ointments
- Gel
- spray
- others
- North america COLD SORE TREATMENT MARKET, BY end user
- overview
- HOme care
- HOspitals
- SPECIALTY CLINICS
- OTHERS
- north america COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
- overview
- Hospitals Pharmacy
- online Pharmacy
- RETAIL Pharmacy
- north america Cold sore treatment market, by country
- overview
- U.S.
- CANADA
- MEXICO
- north america Cold Sore Treatment Market: COMPANY landscape
- company share analysis: north america
- SWOT
- company profile
- GLAXOSMITHKLINE PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ORTHO DERMATOLOGICS’ (A DIVISION OF BAUSCH HEALTH COMPANIES INC.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- FOUNDATION CONSUMER HEALTHCARE
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- NOVARTIS AG
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AMNEAL PHARMACEUTICALS LLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- APOTEX INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CIPLA LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GLENMARK PHARMACEUTICALS, INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICAL LTD.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HIKMA PHARMACEUTICALS PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HRA PHARMA
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- JUBILANT CADISTA (A SUBSIDIARY OF JUBILANT LIFE SCIENCES LIMITED)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- MERIX PHARMACEUTICAL CORP.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SQAUREX
- 17.15.1 COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SUN PHARMACEUTICAL INDUSTRIES LTD.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- VIATRIS INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reportS
表格列表
TABLE 1 COLD SORE TREATMENT Market, pipeline analysis
TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)
TABLE 3 north america COLD SORE TREATMENT Market, By strain TYPE 2019-2028 (USD Million)
TABLE 4 north america COLD SORE TREATMENT Market, By THERAPEUTICS 2019-2028 (USD Million)
TABLE 5 north america ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By therapeutics, 2019-2028 (USD Million)
TABLE 6 north america Analgesic AGENTS in COLD SORE TREATMENT Market, By Therapeutics, 2019-2028 (USD Million)
TABLE 7 north america COLD SORE TREATMENT Market, By drug type 2019-2028 (USD Million)
TABLE 8 north america generics in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)
TABLE 9 north america branded in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)
TABLE 10 north america COLD SORE TREATMENT Market, By dosage type 2019-2028 (USD Million)
TABLE 11 north america Oral segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)
TABLE 12 north america TOPICAL segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)
TABLE 13 north america COLD SORE TREATMENT Market, By END USER 2019-2028 (USD Million)
TABLE 14 north america COLD SORE TREATMENT Market, By distribution channel 2019-2028 (USD Million)
TABLE 15 north america cold sore treatment market, country, 2021-2028 (USD Million)
TABLE 16 U.S. cold sore treatment market, By strain type , 2021-2028 (USD MILLION )
TABLE 17 U.S. cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )
TABLE 18 U.S. anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )
TABLE 19 U.S. analgesics agents in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)
TABLE 20 U.S. cold sore treatment market, By drug Type, 2021-2028 (USD Million)
TABLE 21 U.S. Generics in cold sore treatment market, By drug type, 2021-2028 (USD Million)
TABLE 22 U.S. branded in cold sore treatment market, By drug type , 2021-2028 (USD Million)
TABLE 23 U.S. cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 24 U.S. oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 25 U.S. topical in cold sore treatment market, By dosage type, 2018-2027 (USD Million)
TABLE 26 U.S. cold sore treatment market, By end user, 2021-2028 (USD Million)
TABLE 27 U.S. cold sore treatment market, By distribution channel, 2021-2028 (USD Million)
TABLE 28 CANADA cold sore treatment market, By testing Type, 2021-2028 (USD MILLION )
TABLE 29 CANADA cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )
TABLE 30 CANADA anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )
TABLE 31 CANADA analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)
TABLE 32 CANADA cold sore treatment market, By drug type , 2021-2028 (USD Million)
TABLE 33 CANADA generics in cold sore treatment market, By drug type Type, 2021-2028 (USD Million)
TABLE 34 CANADA branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)
TABLE 35 CANADA cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 36 CANADA oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 37 CANADA topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 38 canada cold sore treatment market, By end user, 2021-2028 (USD Million)
TABLE 39 CANADA cold sore treatment market, By distribution channel, 2021-2028 (USD Million)
TABLE 40 MEXICO cold sore treatment market, By strain Type, 2021-2028 (USD MILLION )
TABLE 41 MEXICO Cold sore treatment market, By THERAPEUTICS, 2021-2028 (Usd million )
TABLE 42 MEXICO anti-viral agents in cold sore treatment market, By THERAPEUTICS, 2021-2028 (USD MILLION )
TABLE 43 MEXICO analgesics in cold sore treatment market, By THERAPEUTICS , 2021-2028 (USD Million)
TABLE 44 MEXICO cold sore treatment market, By drug type , 2021-2028 (USD Million)
TABLE 45 MEXICO generics in cold sore treatment market, By drug Type, 2021-2028 (USD Million)
TABLE 46 MEXICO branded in cold sore treatment market, By drug type, 2021-2028 (USD Million)
TABLE 47 MEXICO cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 48 MEXICO oral in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 49 MEXICO topical in cold sore treatment market, By dosage type , 2021-2028 (USD Million)
TABLE 50 Mexico cold sore treatment market, By end user, 2021-2028 (USD Million)
TABLE 51 MEXICO cold sore treatment market, By distribution type, 2021-2028 (USD Million)
图片列表
FIGURE 1 NORTH AMERICA COLD SORE TREATMENT MARKET: SEGMENTATION
FIGURE 2 north america COLD SORE TREATMENT MARKET : DATA TRIANGULATION
FIGURE 3 north america Cold Sore Treatment Market: DROC ANALYSIS
FIGURE 4 north america Cold Sore Treatment market: north america VS country MARKET ANALYSIS
FIGURE 5 north america Cold Sore Treatment Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 north america Cold Sore Treatment MARKET: MULTIVARIATE MODELLING
FIGURE 7 north america Cold Sore Treatment MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 north america COLD SORE TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 north america COLD SORE TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 north america Cold Sore Treatment MARKET: MARKET drug type COVERAGE GRID
FIGURE 11 north america Cold Sore Treatment market: SEGMENTATION
FIGURE 12 Growing PREVALENCE OF COLD SORE TREATMENT, AND PROLIFERATION IN MODES OF TRANSMISSION of herpes simplex virus (hsv), and increasing awareness about sexually transmitted diseases are DRIVing THE north america Cold Sore treatment market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 HERPES SIMPLEX TYPE 1 VIRUS SEGMENT is expected to account for the largest share of the north america COLD SORE TREATMENT MARKET in 2021 & 2028
FIGURE 14 u.s. is the fastest growing market FOR the Cold Sore Treatment MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA COLD SORE TREATMENT MARKET
FIGURE 16 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, AMONG PERSONS AGED 14-49 YEARS, BY AGE GROUP: IN THE U.S. 2015–2016
FIGURE 17 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY RACE AND HISPANIC ORIGIN: U.S. 2015–2016
FIGURE 18 north america COLD SORE TREATMENT market: BY strain TYPE, 2020
FIGURE 19 north america COLD SORE TREATMENT market: BY strain TYPE, 2020-2028 (USD Million)
FIGURE 20 north america COLD SORE TREATMENT market: BY strain TYPE, CAGR (2021-2028)
FIGURE 21 north america COLD SORE TREATMENT market: BY strain TYPE, LIFELINE CURVE
FIGURE 22 north america COLD SORE TREATMENT market: BY THERAPEUTICS, 2020
FIGURE 23 north america COLD SORE TREATMENT market: BY THERAPEUTICS , 2020-2028 (USD Million)
FIGURE 24 north america COLD SORE TREATMENT market: BY THERAPEUTICS, CAGR (2021-2028)
FIGURE 25 north america COLD SORE TREATMENT market: BY THERAPEUTICS, LIFELINE CURVE
FIGURE 26 north america COLD SORE TREATMENT market: BY drug type, 2020
FIGURE 27 north america COLD SORE TREATMENT market: BY drug type 2020-2028 (USD Million)
FIGURE 28 north america COLD SORE TREATMENT market: BY drug type, CAGR (2021-2028)
FIGURE 29 north america COLD SORE TREATMENT market: BY drug type, LIFELINE CURVE
FIGURE 30 north america COLD SORE TREATMENT market: BY dosage type, 2020
FIGURE 31 north america COLD SORETREATMENT market: BY dosage type 2020-2028 (USD Million)
FIGURE 32 north america COLD SORETREATMENT market: BY dosage type, CAGR (2021-2028)
FIGURE 33 north america COLD SORETREATMENT market: BY dosage type, LIFELINE CURVE
FIGURE 34 north america COLD SORE TREATMENT market: BY END USER, 2020
FIGURE 35 north america COLD SORE TREATMENT market: BY END USER 2020-2028 (USD Million)
FIGURE 36 north america COLD SORE TREATMENT market: BY END USER, CAGR (2021-2028)
FIGURE 37 north america COLD SORE TREATMENT market: BY END USER, LIFELINE CURVE
FIGURE 38 north america COLD SORE TREATMENT market: BY distribution channel, 2020
FIGURE 39 north america COLD SORE TREATMENT market: BY distribution channel 2020-2028 (USD Million)
FIGURE 40 north america COLD SORE TREATMENT market: BY distribution channel, CAGR (2021-2028)
FIGURE 41 north america COLD SORE TREATMENT market: BY distribution channel, LIFELINE CURVE
FIGURE 42 NORTH AMERICA cold sore treatment market: SNAPSHOT (2020)
FIGURE 43 NORTH AMERICA cold sore treatment market: BY country (2020)
FIGURE 44 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)
FIGURE 45 NORTH AMERICA cold sore treatment market: BY country (2021 & 2028)
FIGURE 46 NORTH AMERICA cold sore treatment market: BY strain type (2021-2028)
FIGURE 47 north america cold sore treatment market: company share 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
